Characterization of the Pheochromocytoma-Predominant Subgroup of von Hippel-Lindau Disease. [PDF]
Solomon JR +6 more
europepmc +1 more source
From surgery to systemic therapy in von Hippel-Lindau disease: insights from extended follow-up of LITESPARK-004. [PDF]
Tachiki LM, Tykodi SS.
europepmc +1 more source
Role of Targeted Therapy in the Management of von Hippel-Lindau Disease-Associated Renal Cell Carcinoma: A Single-Proportion Meta-Analysis. [PDF]
Abimbola A +4 more
europepmc +1 more source
Retinal vascular proliferation with fibrotic regression in von Hippel-Lindau disease. [PDF]
Chen JY +4 more
europepmc +1 more source
A New Era of Management of Von Hippel-Lindau Disease-Associated Tumors With Belzutifan. [PDF]
Niccum Haag H.
europepmc +1 more source
Longitudinal Evaluation of Clear-cell Renal Cell Carcinoma in von Hippel-Lindau Disease. [PDF]
Linehan WM +19 more
europepmc +1 more source
The gradual expansion of multiple intramedullary metastatic renal cell carcinoma in a patient with von Hippel-Lindau disease with multiple intramedullary hemangioblastomas: illustrative case. [PDF]
Tsurubuchi T +7 more
europepmc +1 more source
Local tumor control and neurological outcomes after surgery for spinal hemangioblastomas in sporadic and von Hippel-Lindau disease: A multicenter study. [PDF]
Wach J +36 more
europepmc +1 more source
Von Hippel-Lindau disease with ocular and multiple systemic findings. [PDF]
Singh B, Kumari R, Bhagat DK, Bhatia D.
europepmc +1 more source
Von Hippel-Lindau Disease : A Comprehensive Review of Diagnosis, Genetics, Clinical Challenges, and Surveillance. [PDF]
Jung NY, Park JB.
europepmc +1 more source

